vs
和黄医药（HCM）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是LiveRamp Holdings, Inc.的1.3倍（$270.8M vs $212.2M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 0.7%，领先18.1%），LiveRamp Holdings, Inc.同比增速更快（8.6% vs -16.5%）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
HCM vs RAMP — 直观对比
营收规模更大
HCM
是对方的1.3倍
$212.2M
营收增速更快
RAMP
高出25.1%
-16.5%
净利率更高
RAMP
高出18.1%
0.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $212.2M |
| 净利润 | $2.0M | $39.9M |
| 毛利率 | 37.7% | 71.9% |
| 营业利润率 | -13.2% | 18.6% |
| 净利率 | 0.7% | 18.8% |
| 营收同比 | -16.5% | 8.6% |
| 净利润同比 | -83.6% | 255.7% |
| 每股收益（稀释后） | $0.00 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMRAMP
| Q4 25 | $270.8M | $212.2M | ||
| Q3 25 | — | $199.8M | ||
| Q2 25 | $277.7M | $194.8M | ||
| Q1 25 | $324.5M | $188.7M | ||
| Q4 24 | — | $195.4M | ||
| Q3 24 | — | $185.5M | ||
| Q2 24 | $305.7M | $176.0M | ||
| Q1 24 | — | $171.9M |
净利润HCMRAMP
| Q4 25 | $2.0M | $39.9M | ||
| Q3 25 | — | $27.4M | ||
| Q2 25 | $455.0M | $7.7M | ||
| Q1 25 | $11.9M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $25.8M | $-7.5M | ||
| Q1 24 | — | $-5.4M |
毛利率HCMRAMP
| Q4 25 | 37.7% | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | 0.1% | 70.1% | ||
| Q1 25 | 48.0% | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | 41.1% | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率HCMRAMP
| Q4 25 | -13.2% | 18.6% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | -1.3% | 3.7% | ||
| Q1 25 | -5.0% | -6.1% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | -9.0% | -3.0% | ||
| Q1 24 | — | -8.3% |
净利率HCMRAMP
| Q4 25 | 0.7% | 18.8% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | 163.8% | 4.0% | ||
| Q1 25 | 3.7% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | 8.4% | -4.3% | ||
| Q1 24 | — | -3.1% |
每股收益（稀释后）HCMRAMP
| Q4 25 | $0.00 | $0.62 | ||
| Q3 25 | — | $0.42 | ||
| Q2 25 | $0.52 | $0.12 | ||
| Q1 25 | $0.01 | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | $0.03 | $-0.11 | ||
| Q1 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $403.4M |
| 总债务越低越好 | $93.2M | — |
| 股东权益账面价值 | $1.2B | $962.3M |
| 总资产 | $1.8B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMRAMP
| Q4 25 | $1.4B | $403.4M | ||
| Q3 25 | — | $376.9M | ||
| Q2 25 | $1.4B | $371.1M | ||
| Q1 25 | $836.1M | $420.8M | ||
| Q4 24 | — | $384.3M | ||
| Q3 24 | — | $348.4M | ||
| Q2 24 | $802.5M | $342.7M | ||
| Q1 24 | — | $368.9M |
总债务HCMRAMP
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
股东权益HCMRAMP
| Q4 25 | $1.2B | $962.3M | ||
| Q3 25 | — | $943.8M | ||
| Q2 25 | $1.2B | $947.8M | ||
| Q1 25 | $759.9M | $948.9M | ||
| Q4 24 | — | $957.7M | ||
| Q3 24 | — | $932.1M | ||
| Q2 24 | $740.1M | $951.9M | ||
| Q1 24 | — | $949.1M |
总资产HCMRAMP
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | — | $1.2B |
负债/权益比HCMRAMP
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | — |
| 自由现金流经营现金流 - 资本支出 | $3.4M | — |
| 自由现金流率自由现金流/营收 | 1.2% | — |
| 资本支出强度资本支出/营收 | 1.8% | 0.1% |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | — |
8季度趋势，按日历期对齐
经营现金流HCMRAMP
| Q4 25 | $8.2M | — | ||
| Q3 25 | — | $57.4M | ||
| Q2 25 | $-72.9M | $-15.8M | ||
| Q1 25 | $40.3M | — | ||
| Q4 24 | — | $45.1M | ||
| Q3 24 | — | $55.6M | ||
| Q2 24 | $-39.8M | $-9.3M | ||
| Q1 24 | — | — |
自由现金流HCMRAMP
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | $-82.2M | $-16.2M | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | — | $55.4M | ||
| Q2 24 | $-49.9M | $-9.6M | ||
| Q1 24 | — | — |
自由现金流率HCMRAMP
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | -29.6% | -8.3% | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | -16.3% | -5.4% | ||
| Q1 24 | — | — |
资本支出强度HCMRAMP
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | 3.3% | 0.2% | ||
| Q1 25 | 2.4% | 0.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | — | 1.0% |
现金转化率HCMRAMP
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | -0.16× | -2.04× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
